December 1, 2022
On November 30, the Minnesota Department of Health (MDH) announced that it will add irritable bowel syndrome (IBS) and obsessive-compulsive disorder (OCD) to the list of qualifying medical conditions for participation in Minnesota’s Medical Cannabis Program.
The new qualifying conditions will take effect August 1, 2023.
No petitions for new delivery methods were considered this year. Petitions for gastroparesis and opioid use disorder were not approved.
As in past years, MDH conducted a formal petitioning process to solicit public input on potential qualifying medical conditions and delivery methods for medicine. Minnesotans submitted petitions in June and July. Following that, the process moved into a public comment period and a review panel. MDH staff prepared reports that summarized research pertaining to the use of medical cannabis for each proposed condition.
Click here to see the entire list of qualifying conditions.
December 4, 2025
On December 4, Minnesota Management and Budget (MMB) released its budget forecast for the 2026-27 biennium, showing a short-term budget surplus of $2.5 billion for the current biennium, but warned of a long-term $2.96 billion deficit for the 2028-29 biennium.
December 4, 2025
On December 2, the Vaccine Integrity Project (VIP) released a study on the safety, effectiveness, and public health impact of hepatitis B virus (HBV) vaccinations at birth.
December 4, 2025
The Minnesota Department of Commerce (DOC) is now accepting public comments regarding proposed legislation to mandate insurance coverage of certain treatments.